Ora Launches the Ora Eyecup, an Ophthalmic Research Technology at Eyecelerator 2022

Ora has formally launched a mobile research platform, Ora EyeCup, which promises to transform patient data capture through high-resolution imaging, artificial intelligence (AI) analysis, and real-time patient feedback. The Ora EyeCup, a finalist in the Most Valuable Clinical Technology Award category at the Reuters Events Pharma Awards USA 2022, will be presented by Dr. Gustavo De Moraes, chief medical officer at Ora, at this year’s Eyecelerator Conference in Chicago, IL, on September 29th. 

The Ora EyeCup platform is a combination of hardware and software—a smartphone attachment and software application which allows patients to take high-resolution images of their eyes and track disease signs and symptoms remotely. With over 138,000 images captured to date, 98% are considered gradable by researchers and AI. Post-capture processing utilizes AI-powered image analysis for precise clinical assessments of ocular redness, tear film stability, and corneal health. Along with this, the Ora EyeCup ensures protocol adherence through compliance assurance diaries for both symptom tracking and therapy dosing.  

“At Ora, our technologists have spent the past 2 years developing this revolutionary system to capture patient data and provide a deeper understanding of therapeutic effect,” notes Dr. De Moraes. “The result is a trailblazing technology that captures high quality therapeutic data and improves the likelihood of study success.”

Ora EyeCup is now available to enhance the quality of your ophthalmic clinical trial. To learn more about Ora EyeCup and how this hardware and software solution can strengthen your next ophthalmic clinical study, please reach out at info@oraclinical.com or visit the Ora Eyecup website.